Authors
Latest:
Impact of Inpatient Pharmacist Review of Discharge AntibioticsA food for thought as an ambulatory antibiotic stewardship initiative.
Latest:
Ready, Set, Cabenuva: Implementing Cabotegravir/RilpivirineThis novel therapeutic option represents the first long-acting injectable approved for maintenance of HIV-1 suppression.
Latest:
Mpox and Concerns Around the Disease in the United StatesScott Bertani, who is the director of Advocacy of the National Coalition for LGBTQ Health, discusses what the new mpox health declarations mean to the US, which groups are high risk, and information about the vaccine to prevent the disease.
Latest:
The Next Generation of COVID-19 Vaccines and BoostersWill there be an answer to keep the continuously evolving virus at bay? Are seasonal combination vaccines the wave of the future?
Latest:
Hepatitis B Vaccination Increases Survival of Patients with Chronic Liver DiseaseHepatitis B virus vaccination shown to to significantly improve survival rates for patients with chronic hepatitis C, nonalcoholic liver disease, and liver cirrhosis.
Latest:
Barriers to Health Care Transition in Adolescents and Young Adults With Early Acquired HIV InfectionUnique challenges can affect the success of the shift from pediatric to adult care settings.
Latest:
Tips for Talking with Patients about Fecal Microbiota Transplant for Recurrent C. difficile InfectionsTo close the discussion, experts on C. difficile infections discuss how they talk with patients about fecal microbiota transplantation.
Latest:
Shionogi's Strategies for Addressing Antibiotic Efficacy and ResistanceChristine Slover, PharmD discussed cefiderocol's effectiveness against challenging infections, including those caused by multi-drug resistant bacteria.
Latest:
Science Is Science: Navigating Clinical Trust Amid Political ShiftsSu H Wang, MD, FACP, MPH discusses combating vaccine misinformation, preventing outbreaks, and highlighting global health interconnectedness
Latest:
Unmasking the Infodemic: The Impact of COVID-19 Misinformation on Public HealthSocial media platforms, public health agencies, and communities must join forces to stop the rapid spread of false information.
Latest:
New Fecal Microbiota Options for Prevention of Recurrent Clostridioides difficileWith the addition of 2 new live biotherapeutic products, a clinician reviews the application, storage and administration techniques for them.
Latest:
Daptomycin as Frontline Therapy for MRSA Bacteremia: Has the Time Come?Findings increasingly suggest the mortality risk may be reduced by initiating daptomycin within 3 days of infection.
Latest:
The Final Antibiotic Symphony: Harmonizing Diagnostic Accuracy with Antibiotic Treatment in Native Joint Septic ArthritisA study underscores the microbial etiology of septic arthritis, which can guide clinicians in minimizing the use of overly broad empiric antibiotics.
Latest:
COVID-19–Associated Fungal Infections During EMCO: Review of Epidemiology, Diagnosis, and PharmacotherapyExamining pharmacological management in COVID-19 patients with ARDS requiring antifungal therapy during extracorporeal life support.
Latest:
Getting Help from HAL: Applying Machine Learning to Predict Antibiotic ResistanceA pair of experts assess literature on the means of interpreting hospitalized patient antibiotic resistance through machine learning.
Latest:
Pfizer’s RSVpreF Vaccine Shows Efficacy in High-Risk Adults Aged 18-59Study results show that the vaccine elicits a comparable immune response in high-risk adults aged 18-59 with chronic medical conditions, suggesting potential for broader vaccination efforts.
Latest:
Emergency Department Antimicrobial Stewardship: A Critical Area of Focus for Health SystemsAs the first line of acute care, emergency departments are key stewards of antibiotics.
Latest:
Real-World Effectiveness of Cefiderocol in Treating Serious Gram-Negative Infections: Insights from the PROVE StudyCornelius Clancy, MD, highlights the real-world outcomes of cefiderocol treatment for serious gram-negative bacterial infections, reporting a clinical success rate of 75% along with encouraging safety data.
Latest:
Sorry Ganciclovir, You’re Just Not the One for MeImportant clinical considerations to know about resistant CMV infections.
Latest:
Emergency Department Antimicrobial Stewardship: A Critical Area of Focus for Health SystemsAs the first line of acute care, emergency departments are key stewards of antibiotics.
Latest:
To Prophylax or not to Prophylax: Preventing CDIClinicians look at optimal approaches for trying to avoid Clostridioides difficile infection (CDI).
Latest:
STAY PrEPARED: Understanding COVID-19 Pre-Exposure ProphylaxisNew therapeutics offer some hope in this emerging market.
Latest:
Top 5 Tips for Teaching ID LearnersThe latest article from SIDP offers a Top 5 list of how to precept a learner on an infectious disease rotation.
Latest:
Combination Antifungal for Invasive Mucormycosis: Yay or Nay?There is limited and conflicting data regarding the role of combination antifungal therapy for treatment of invasive mucormycosis.
Latest:
Mixed Fungal Brain AbscessClinicians review a patient case including diagnosis, treatment, and follow-up.
Latest:
NAFLD Is Increasingly Affecting Patients With HIVThe prevalence of this disease in this patient population is much higher than in the general public.
Latest:
SPREADing the Love: The Importance of Mentorship in PharmacyIn the latest column from SIDP, the authors discuss having leaders to help navigate school and beyond.
Latest:
ViiV Healthcare Presents Potential Long-Acting HIV TherapiesPhase 1 data on VH184, a third-generation integrase strand transfer inhibitor, and VH499, a novel HIV-1 capsid inhibitor, highlighting their antiviral potency, safety profiles, and potential for long-acting injectable formulations.
